Molecular 'on-off' switch for Parkinson's disease discovered

May 23, 2012

(Medical Xpress) -- Scientists at the Medical Research Council (MRC) Protein Phosphorylation Unit at the University of Dundee have discovered a new molecular switch that acts to protect the brain from developing Parkinson's disease.

The findings have helped scientists understand how in a gene called PINK1 lead to Parkinson's in patients as young as 8 years old - which could eventually lead to new ways to diagnose and treat the condition.

The job of some proteins inside cells is to switch other important proteins on or off. Understanding how these proteins work and which proteins they target could be the key to why die in Parkinson's - and how we can save them.

But despite intensive research, the target of the PINK1 enzyme (which is made by the PINK1 gene) has eluded scientists for almost a decade.

Now the Dundee team has found that PINK1 switches on a protein called , whose main job is to keep cells healthy by removing damaged proteins. Mutations in the gene that makes Parkin can also cause inherited forms of Parkinson's in younger patients .

The team was led jointly by Dr Miratul Muqit and Professor Dario Alessi at the University of Dundee.

"Parkinson's is a devastating and currently we have no drugs in the clinic that can cure or slow the disease down," said Dr Muqit, a Wellcome Trust Clinician Scientist in the MRC Unit.

"Over the last decade, many genes have been linked to Parkinson's but a major roadblock has been determining the function of these genes in the brain and how the mutations lead to brain degeneration."

Dr Muqit said, "Our work suggests this pathway can't be switched on in Parkinson's patients with genetic mutations in or Parkin. More research will be needed to see whether this also happens in Parkinson's patients who do not carry these mutations."

Professor Alessi, Director of the MRC Phosphorylation Unit, added, "Now that we have identified this pathway, the key next step will be to identify the nature of these damaged proteins that are normally removed by Parkin. Although further studies are required, our findings also suggest that designer drugs that switch this pathway on could be used to treat Parkinson's."

The research was funded by the Medical Research Council, Wellcome Trust, Parkinson's UK, the J. Macdonald Menzies Charitable Trust and the Michael J. Fox Foundation.

The research is published in the latest edition of the journal Open Biology. The paper was co-authored with Dr Helen Walden from Cancer Research UK's London Research Institute.

Explore further: Vitamin K2: New hope for Parkinson's patients?

Related Stories

Vitamin K2: New hope for Parkinson's patients?

May 11, 2012
Neuroscientist Patrik Verstreken, associated with VIB and KU Leuven, succeeded in undoing the effect of one of the genetic defects that leads to Parkinson's using vitamin K2. His discovery gives hope to Parkinson's patients. ...

Why do neurons die in Parkinson's disease?

November 10, 2011
Current thinking about Parkinson's disease is that it's a disorder of mitochondria, the energy-producing organelles inside cells, causing neurons in the brain's substantia nigra to die or become impaired. A study from Children's ...

Protein linked to Parkinson's disease may regulate fat metabolism

August 25, 2011
National Institutes of Health researchers have found that Parkin, an important protein linked with some cases of early-onset Parkinson's disease, regulates how cells in our bodies take up and process dietary fats.

Recommended for you

Parkinson's is partly an autoimmune disease, study finds

June 21, 2017
Researchers have found the first direct evidence that autoimmunity—in which the immune system attacks the body's own tissues—plays a role in Parkinson's disease, the neurodegenerative movement disorder. The findings raise ...

Predicting cognitive deficits in people with Parkinson's disease

June 20, 2017
Parkinson's disease (PD) is commonly thought of as a movement disorder, but after years of living with PD approximately twenty five percent of patients also experience deficits in cognition that impair function. A newly developed ...

Pre-clinical study suggests Parkinson's could start in gut endocrine cells

June 15, 2017
Recent research on Parkinson's disease has focused on the gut-brain connection, examining patients' gut bacteria, and even how severing the vagus nerve connecting the stomach and brain might protect some people from the debilitating ...

Hi-res view of protein complex shows how it breaks up protein tangles

June 15, 2017
Misfolded proteins are the culprits behind amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and other neurodegenerative brain disorders. These distorted proteins are unable to perform their normal ...

CRISPR tech leads to new screening tool for Parkinson's disease

June 5, 2017
A team of researchers at the University of Central Florida is using breakthrough gene-editing technology to develop a new screening tool for Parkinson's disease, a debilitating degenerative disorder of the nervous system. ...

Infection with seasonal flu may increase risk of developing Parkinson's disease

May 30, 2017
Most cases of Parkinson's have no known cause, and researchers continue to debate and study possible factors that may contribute to the disease. Research reported in the journal npj Parkinson's Disease suggests that a certain ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.